ASU FC S. M. DELLA MISERICORDIA; Oncologia

Udine, Friuli Venezia Giulia 33100

0 studies enrolling now · 1 studies all time

What they study most

Triple-Negative Breast Cancer

Studies at this site

• A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer — Completed